Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker

MLA

Irina Ostrovnaya, et al. “Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker.” Journal of Computer Assisted Tomography, vol. 43, Jan. 2019, pp. 628–33. EBSCOhost, https://doi.org/10.1097/rct.0000000000000877.

APA

Irina Ostrovnaya, Oguz Akin, Binsheng Zhao, Lyndon Luk, Lawrence H. Schwartz, Emily C. Zabor, Firas S. Ahmed, Hiram Shaish, Hao Yang, A. Ari Hakimi, & Xiaotao Guo. (2019). Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker. Journal of Computer Assisted Tomography, 43, 628–633. https://doi.org/10.1097/rct.0000000000000877

Chicago

Irina Ostrovnaya, Oguz Akin, Binsheng Zhao, Lyndon Luk, Lawrence H. Schwartz, Emily C. Zabor, Firas S. Ahmed, et al. 2019. “Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker.” Journal of Computer Assisted Tomography 43 (January): 628–33. doi:10.1097/rct.0000000000000877.